Skip to main content
. 2022 Sep 26;2022(9):CD015048. doi: 10.1002/14651858.CD015048.pub2

Comparison 13. IDS: LVRD (> 1 cm) versus NMRD.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
13.1 Overall survival 1   Hazard Ratio (IV, Random, 95% CI) 2.23 [1.49, 3.34]
13.1.1 ≤ 4 cycles of NACT 1   Hazard Ratio (IV, Random, 95% CI) 1.77 [1.07, 2.93]
13.1.2 > 4 cycles of NACT 1   Hazard Ratio (IV, Random, 95% CI) 2.67 [1.76, 4.06]